Clinical Trial Update: 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating 4'-Thio-araC (thiarabine) in advanced hematologic malignancies, including leukemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• 4'-Thio-araC (Thiarabine) (thiarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED